Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 8/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 6/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL432956 | 0.82 | OPRK1 (0.46) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL432352 | 0.81 | OPRK1 (0.60) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL10083719 | 0.81 | OPRK1 (0.44) | OPRK1OPRM1OPRD1CYP2D6 | |
| Hydrochloric Acid SCHEMBL434825 | 0.80 | OPRK1 (0.43) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL434038 | 0.76 | OPRK1 (0.42) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL434349 | 0.76 | ITGA4 (0.44) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL10083292 | 0.76 | OPRK1 (0.52) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL15385502 | 0.76 | ITGA4 (0.44) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL433988 | 0.76 | OPRK1 (0.52) | OPRK1OPRM1OPRD1CYP2D6 | |
| SCHEMBL434260 | 0.76 | OPRK1 (0.52) | OPRK1OPRM1OPRD1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9303027-B2 | Kappa opioid receptor agonists | DR. REDDY'S LABORATORIES LTD. (IN) | 2016-04-05 | — | — | US | claimed |
| US-20130303525-A1 | KAPPA OPIOID RECEPTOR AGONISTS | DR. REDDY'S LABORATORIES, INC. (US) | 2013-11-14 | — | — | US | claimed |
| US-9303027-B2 | Kappa opioid receptor agonists | DR. REDDY'S LABORATORIES LTD. (IN) | 2016-04-05 | — | — | US | disclosed |
| US-20130303525-A1 | KAPPA OPIOID RECEPTOR AGONISTS | DR. REDDY'S LABORATORIES, INC. (US) | 2013-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303525-A1 | KAPPA OPIOID RECEPTOR AGONISTS | OPRK1, OPRL1, OPRD1 | OPRK1 1/4885OPRM1 4/4885OPRD1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.